The FDA has accepted the new drug application (NDA) for SH 201, the first palatable oral liquid of the related chemotherapeutic agent, for the treatment of certain forms of leukemia and other cancers
Foundation Medicine, Inc. announced that the FDA approved FoundationOne Liquid CDx, the Company’s comprehensive pan-tumor liquid biopsy test.
AErrane is a volatile halogenated anaesthetic for general inhalation anaesthesia
The FDA has approved Gammagard Liquid 10% [Immune Globulin Infusion (Human)] as a treatment for Mmultifocal Motor Neuropathy (MMN). This is...
Desflurane is indicated as an inhalation agent for induction and/or maintenance of anaesthesia for inpatient and outpatient surgery in adults and maintenance of anaesthesia for inpatient and outpatient paediatric surgery.